Drugs / FS VH S/D 4 s-apr
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00999141 | Sep → Dec 2009 | — | Baxter Healthcare Corporation | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FS VH S/D 4 s-apr | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00999141 ↗ |
| Modality | Protein / enzyme biologic | “fibrin sealant VH S/D 4 s-apr (Artiss) to improve tissue adherence” PMID 23563904 ↗ Apr 2013 |
| Route | Topical | “intraoperative, topical administration” NCT00999141 ↗ |